Login to Your Account



Hong Kong's Uni-Bio teams up with Sun-Novo in diabetes treatment

By Pearl Liu
Staff Writer

Tuesday, December 27, 2016

HONG KONG – Looking to tap into the drastically underserviced market for diabetes treatments in China, biopharma company Uni-Bio Science Group plans to develop and introduce new diabetes drugs by partnering with a local CRO.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription